Braidwell LP Portfolio Holdings

Braidwell LP

  • $1.63 Billion
  • Q2 2025

Braidwell LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $1.63 Billion distributed in 55 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Neurocrine Biosciences Inc with a value of $146M, Xenon Pharmaceuticals Inc. with a value of $113M, Argenx Se with a value of $107M, Krystal Biotech, Inc. with a value of $100M, and Align Technology Inc with a value of $94M.

Examining the 13F form we can see an increase of $3.38M in the current position value, from $1.63B to 1.63B.

Braidwell LP is based out at Stamford, CT

Below you can find more details about Braidwell LP portfolio as well as his latest detailed transactions.

Portfolio value $1.63 Billion
Healthcare: $1.63 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$245B
$15.4 Million 0.94% of portfolio
49,400
Q2 2025 New

Summary

  • Portfolio
  • No. of Stocks 55
  • Current Value $1.63 Billion
  • Prior Value $1.63 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 7 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 19 stocks
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email